Yasser Albogami

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Risk Assessment

Top Venues

Therapeutic advances in drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Yasser Albogami, Almaha Alfakhri, Abdulaziz Alaqil, Aljawharah Alkoraishi, Heba Alshammari, Yasmin Elsharawy, Abdullah Alhammad, Abdulaziz Alhossan
Safety and quality of AI chatbots for drug-related inquiries: A real-world comparison with licensed pharmacists. Digital health 10 (2024)
Yasser Albogami, Almaha Alfakhri, Abdulaziz Alaqil, Aljawharah Alkoraishi, Heba Alshammari, Yasmin Elsharawy, Abdullah Alhammad, Abdulaziz Alhossan
Safety and quality of AI chatbots for drug-related inquiries: A real-world comparison with licensed pharmacists. Digital health 10 (2024)
Yasser Albogami, Ohoud Almadani, Sumaya N Almohareb, Sultan Alshehri, Abdullah Alkhaibari, Mona Anzan, Alaa Alsharif, Abdulaziz Alhossan, Adel Alrwisan
Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020. Therapeutic advances in drug safety 15 (2024)
Yasser Albogami, Amir Sarayani, Juan M Hincapie-Castillo, Almut G Winterstein
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015. Drug safety 44 (4) (2021)
Yasser Albogami, Kenneth Cusi, Michael J Daniels, Yu-Jung J Wei, Almut G Winterstein
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes care 44 (6) (2021)
Yasser Albogami, Yu-Jung J Wei, Almut G Winterstein
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data. Pharmacoepidemiology and drug safety (2021)
Yasser Albogami, Kenneth Cusi, Michael J Daniels, Yu-Jung J Wei, Almut G Winterstein
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352. Diabetes care 44 (8) (2021)